To understand the impact of PTEN loss on genomic features of cancer progression, we analyzed the total number of mutations, percent genome altered by losses and gains, intratumor heterogeneity, aneuploidy, and homologous repair defects across the pan-cancer cohort (Fig. 4a–d). The gene discussed is PTEN; the disease is cancer.